Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, French Cryptococcosis Study Group. · 2007

Read Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. by Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, French Cryptococcosis Study Group. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1808080.txt.

Description

Dromer and the French Cryptococcosis Study Group ran CryptoA/D in 2007, a France-wide study of cryptococcosis from 1997 to 2001. The disease is a life-threatening fungal infection caused by Cryptococcus neoformans. Most prior guidance came from trials in HIV patients with brain infection, run before modern HIV therapy.

The prospective study enrolled 230 patients without trial selection bias. Of them, 77 percent were HIV-positive, and 72.5 percent carried fungal serotype A rather than serotype D. Men, HIV-positive patients, and those whose fungus was serotype A all had more severe disease. Failure to clear the fungus by week two was tied to wide initial spread and to high blood antigen levels. Missing the drug flucytosine in early therapy also predicted failure, with odds near four times higher.

Catalog record

CREATORDromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, French Cryptococcosis Study Group.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1808080

Browse the full library · About the Tower of Babel